Flagship Harbor Advisors’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
VCM
CAM
BL
S
VFT
MFIM
Flagship Harbor Advisors's ICCC Position: Q1 2026 in Review
Flagship Harbor Advisors sold out of ImmuCell (ICCC) in Q1 2026, closing a stake of 730 shares — an estimated $4.49K sold.
Flagship Harbor Advisors first reported a position in ICCC in Q2 2018 and held it in 19 quarters. The position peaked at $168K in Q3 2021. 27 funds tracked by Wall St. Rank hold ICCC as of Q1 2026.
- Flagship Harbor Advisors reported no remaining ImmuCell position as of Q1 2026 after selling out during the quarter.
- Flagship Harbor Advisors sold 730 ImmuCell shares in Q1 2026, an estimated $4.49K.
- Flagship Harbor Advisors first reported a position in ImmuCell in Q2 2018 and held it in 19 quarters.
- Flagship Harbor Advisors's ImmuCell position peaked at $168K in Q3 2021.
- 27 funds tracked by Wall St. Rank held ImmuCell as of Q1 2026.
Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.